These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Radiofrequency catheter ablation in patients with symptomatic atrial flutter/tachycardia after orthotopic heart transplantation. Li YG; Grönefeld G; Israel C; Lu SB; Wang QS; Hohnloser SH Chin Med J (Engl); 2006 Dec; 119(24):2036-41. PubMed ID: 17199953 [TBL] [Abstract][Full Text] [Related]
25. Effects of the NA+ channel blocker pilsicainide on the electrophysiologic properties of pulmonary veins in patients with atrial fibrillation. Kumagai K; Tojo H; Noguchi H; Yasuda T; Ogawa M; Nakashima H; Zhang B; Saku K J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1396-401. PubMed ID: 15610286 [TBL] [Abstract][Full Text] [Related]
26. High-resolution mapping around the crista terminalis during typical atrial flutter: new insights into mechanisms. Tai CT; Huang JL; Lee PC; Ding YA; Chang MS; Chen SA J Cardiovasc Electrophysiol; 2004 Apr; 15(4):406-14. PubMed ID: 15089988 [TBL] [Abstract][Full Text] [Related]
27. Dose-related cardiac electrophysiological effects of intravenous magnesium. A double-blind placebo-controlled dose-response study in patients with paroxysmal supraventricular tachycardia. Christiansen EH; Frost L; Andreasen F; Mortensen P; Thomsen PE; Pedersen AK Europace; 2000 Oct; 2(4):320-6. PubMed ID: 11194599 [TBL] [Abstract][Full Text] [Related]
28. Identification and ablation of atypical atrial flutter. Entrainment pacing combined with electroanatomic mapping. Horlitz M; Schley P; Shin DI; Ghouzi A; Sause A; Wehner M; Müller M; Klein RM; Bufe A; Gülker H Z Kardiol; 2004 Jun; 93(6):463-73. PubMed ID: 15252740 [TBL] [Abstract][Full Text] [Related]
29. [Simplified approach to ablation in atrial flutter using a single catheter electrode. Based on 70 cases]. Albenque JP; Donzeau JP; Goutner C; Dechandol AM; Berthoumieu-Bolinelli H; Charrancon M Arch Mal Coeur Vaiss; 1999 Apr; 92(4):387-92. PubMed ID: 10326146 [TBL] [Abstract][Full Text] [Related]
31. Acute success and persistence of bidirectional conduction block in the cavotricuspid isthmus one month post cryocatheter ablation of common atrial flutter. Kuniss M; Kurzidim K; Greiss H; Berkowitsch A; Sperzel J; Hamm C; Pitschner HF Pacing Clin Electrophysiol; 2006 Feb; 29(2):146-52. PubMed ID: 16492299 [TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of a simplified approach for common atrial flutter radio frequency ablation with only two catheters. Klug D; Lacroix D; Marquié C; Mairesse G; Alix D; Dennetière S; d'Hautefeuille B; Zghal N; Kacet S Europace; 2001 Jul; 3(3):208-15. PubMed ID: 11467462 [TBL] [Abstract][Full Text] [Related]
33. Role of electrophysiological study and ablation in the management of recurrent atrial flutter associated with haemodynamic compromise in a critically ill patient. Kojodjojo P; Kanagaratnam P; Davies DW; Peters NS; Markides V Anaesthesia; 2005 May; 60(5):505-8. PubMed ID: 15819773 [TBL] [Abstract][Full Text] [Related]
34. Novel method to assess cardiac electrophysiology in the rat: characterization of standard ion channel blockers. Regan CP; Cresswell HK; Zhang R; Lynch JJ J Cardiovasc Pharmacol; 2005 Jul; 46(1):68-75. PubMed ID: 15965357 [TBL] [Abstract][Full Text] [Related]
35. In vivo cardiac electrophysiologic and antiarrhythmic effects of an isoquinoline IKur blocker, ISQ-1, in rat, dog, and nonhuman primate. Regan CP; Stump GL; Wallace AA; Anderson KD; McIntyre CJ; Liverton NJ; Lynch JJ J Cardiovasc Pharmacol; 2007 Apr; 49(4):236-45. PubMed ID: 17438409 [TBL] [Abstract][Full Text] [Related]
36. Verapamil toxicity causing anterograde atrioventricular blockade with preserved retrograde conduction: An electrophysiological paradox. Jacob S; Bharadwaj AS; Ganguly J; Kottam A Cardiol J; 2010; 17(6):636-7. PubMed ID: 21154272 [No Abstract] [Full Text] [Related]
37. Hemodynamic and electrophysiologic effects of acute chocolate ingestion in young adults. Baron AM; Donnerstein RL; Samson RA; Baron JA; Padnick JN; Goldberg SJ Am J Cardiol; 1999 Aug; 84(3):370-3, A10. PubMed ID: 10496460 [TBL] [Abstract][Full Text] [Related]
38. Advances in the Pharmacologic Management of Atrial Fibrillation. Burashnikov A; Antzelevitch C Card Electrophysiol Clin; 2011 Mar; 3(1):157-167. PubMed ID: 21731596 [No Abstract] [Full Text] [Related]
39. A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter. Toivonen L; Raatikainen P; Walfridsson H; Englund A; Hegbom F; Anfinsen OG; Gjesdal K; Pehrson S; Johansson S; Frison L; Berggren AR; Edvardsson N J Cardiovasc Pharmacol; 2010 Sep; 56(3):300-8. PubMed ID: 20588189 [TBL] [Abstract][Full Text] [Related]
40. QT response after a test dose and during maintenance therapy with AZD1305 in patients with atrial fibrillation: a double-blind, randomized, placebo-controlled trial. Egstrup K; Bergfeldt L; Duris T; Gullestad L; Kochmanski M; Kuśnierz B; Nielsen T; Sawicki S; Aunes-Jansson M; Edvardsson N; Frison L; Johansson S; Berggren A Am J Cardiovasc Drugs; 2011 Jun; 11(3):199-208. PubMed ID: 21619383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]